|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
1992-9-30
|
|
pubmed:abstractText |
The relation between cardiac mortality and antiarrhythmic drug administration has not been fully determined. This relation was analyzed in 1,330 patients enrolled in the Stroke Prevention in Atrial Fibrillation Study, a randomized clinical trial comparing warfarin, aspirin and placebo for the prevention of ischemic stroke or systemic embolism in patients with nonvalvular atrial fibrillation.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0735-1097
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
20
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
527-32
|
|
pubmed:dateRevised |
2010-3-24
|
|
pubmed:meshHeading |
pubmed-meshheading:1512329-Anti-Arrhythmia Agents,
pubmed-meshheading:1512329-Arrhythmias, Cardiac,
pubmed-meshheading:1512329-Atrial Fibrillation,
pubmed-meshheading:1512329-Death, Sudden, Cardiac,
pubmed-meshheading:1512329-Female,
pubmed-meshheading:1512329-Follow-Up Studies,
pubmed-meshheading:1512329-Heart Failure,
pubmed-meshheading:1512329-Heart Ventricles,
pubmed-meshheading:1512329-Humans,
pubmed-meshheading:1512329-Male,
pubmed-meshheading:1512329-Middle Aged,
pubmed-meshheading:1512329-Risk Factors,
pubmed-meshheading:1512329-Survival Rate
|
|
pubmed:year |
1992
|
|
pubmed:articleTitle |
Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators.
|
|
pubmed:affiliation |
University of Missouri, Columbia.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.,
Randomized Controlled Trial
|
